These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 14607764)
21. Fondaparinux: a new synthetic and selective inhibitor of Factor Xa. Bauer KA Best Pract Res Clin Haematol; 2004 Mar; 17(1):89-104. PubMed ID: 15171960 [TBL] [Abstract][Full Text] [Related]
22. Heparins, low-molecular-weight heparins, and pentasaccharides. Dinwoodey DL; Ansell JE Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464 [TBL] [Abstract][Full Text] [Related]
23. Pentasaccharides. The new anticoagulants. Abdel-Razeq H Saudi Med J; 2004 Aug; 25(8):983-90. PubMed ID: 15322584 [TBL] [Abstract][Full Text] [Related]
24. From heparins to factor Xa inhibitors and beyond. Alban S Eur J Clin Invest; 2005 Mar; 35 Suppl 1():12-20. PubMed ID: 15701143 [TBL] [Abstract][Full Text] [Related]
25. The use of low-molecular-weight heparins in pregnancy--how safe are they? Deruelle P; Coulon C Curr Opin Obstet Gynecol; 2007 Dec; 19(6):573-7. PubMed ID: 18007136 [TBL] [Abstract][Full Text] [Related]
26. Minimising the risk of heparin-induced osteoporosis during pregnancy. Hawkins D; Evans J Expert Opin Drug Saf; 2005 May; 4(3):583-90. PubMed ID: 15934862 [TBL] [Abstract][Full Text] [Related]
27. The use of unfractionated heparin and low molecular weight heparins in pregnancy. Casele HL Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684 [TBL] [Abstract][Full Text] [Related]
28. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes. Haas S Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477 [TBL] [Abstract][Full Text] [Related]
29. Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractioned heparin and fondaparinux. Harr T; Scherer K; Tsakiris DA; Bircher AJ Allergy; 2006 Jun; 61(6):787-8. PubMed ID: 16677252 [No Abstract] [Full Text] [Related]
30. Bemiparin: second-generation, low-molecular-weight heparin for treatment and prophylaxis of venous thromboembolism. Martínez-González J; Vila L; Rodríguez C Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):793-802. PubMed ID: 18570617 [TBL] [Abstract][Full Text] [Related]
31. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin. Ghosh K; Shetty S; Vora S; Salvi V Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603 [TBL] [Abstract][Full Text] [Related]
32. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123 [TBL] [Abstract][Full Text] [Related]
33. Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent. Walenga JM; Jeske WP; Samama MM; Frapaise FX; Bick RL; Fareed J Expert Opin Investig Drugs; 2002 Mar; 11(3):397-407. PubMed ID: 11866668 [TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population. Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443 [TBL] [Abstract][Full Text] [Related]
35. The pharmacoeconomics of deep vein thrombosis treatment. Shorr AF Am J Med; 2007 Oct; 120(10 Suppl 2):S35-41. PubMed ID: 17916458 [TBL] [Abstract][Full Text] [Related]
36. Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues. Blackmer AB; Oertel MD; Valgus JM Ann Pharmacother; 2009 Oct; 43(10):1636-46. PubMed ID: 19737996 [TBL] [Abstract][Full Text] [Related]
37. Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy. Maetzke J; Hinrichs R; Staib G; Scharffetter-Kochanek K Allergy; 2004 Feb; 59(2):237-8. PubMed ID: 14763948 [No Abstract] [Full Text] [Related]